Jounce Therapeutics Inc
(JNCE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 150,572 | 95,529 | 147,493 | 53,241 | 47,906 |
| Marketable Securities | 38,970 | 83,037 | 58,985 | 115,602 | 141,968 |
| TOTAL | $197,231 | $190,827 | $211,391 | $173,697 | $192,209 |
| Non-Current Assets | |||||
| PPE Net | 3,721 | 4,882 | 7,336 | 10,672 | 13,540 |
| Investments And Advances | 0 | 41,657 | 6,710 | 1,601 | 5,990 |
| Other Non-Current Assets | 11,598 | 15,330 | 18,799 | 19,912 | 2,713 |
| TOTAL | $15,319 | $61,869 | $32,845 | $32,185 | $22,243 |
| Total Assets | $212,550 | $252,696 | $244,236 | $205,882 | $214,452 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,095 | 1,674 | 2,036 | 2,460 | 3,272 |
| Accrued Expenses | 17,145 | 13,467 | 12,044 | 8,907 | 6,952 |
| Other current liabilities | 178 | 62 | 42 | 132 | 165 |
| TOTAL | $23,568 | $18,898 | $19,324 | $14,400 | $65,546 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | 1,931 | N/A | 55,157 |
| Other Non-Current Liabilities | 5,870 | 9,993 | 13,618 | 16,889 | 2,062 |
| TOTAL | $5,870 | $9,993 | $13,618 | $16,889 | $44,777 |
| Total Liabilities | $29,438 | $28,891 | $32,942 | $31,289 | $110,323 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 52,140 | 51,665 | 45,394 | 34,049 | 32,972 |
| Common Shares | 51 | 51 | 42 | 34 | 33 |
| Retained earnings | -292,792 | -241,873 | -151,001 | -107,159 | -163,907 |
| Other shareholders' equity | -677 | -238 | -17 | 54 | -78 |
| TOTAL | $183,112 | $223,805 | $211,294 | $174,593 | $104,129 |
| Total Liabilities And Equity | $212,550 | $252,696 | $244,236 | $205,882 | $214,452 |